Purpose: To determine a possible implication of CD21, CD35, and CD55 in the pathogenesis of age-related macular degeneration (AMD) by assessing the difference in expression rates of these factors on AMD patients and a control group.
Design: Case-control study.
Methods: Fifty unrelated AMD patients and 48 unrelated sex- and age-matched control subjects participated in this case-control study.